Entry Detail



General Information

Database ID:exR0080597
RNA Name:RPL32
RNA Type:mRNA
Chromosome:chr3
Starnd:-
Coordinate:
Start Site(bp):12834485End Site(bp):12841582
External Links:ENSG00000144713



Disease Information

Disease Name:Fragile X Syndrome
Disease Category:Congenital, Hereditary, and Neonatal Diseases and Abnormalities
MeSH ID:D005600
Type:Diseases Category/Congenital, Hereditary, and Neonatal Diseases and Abnormalities
Alias:Fragile X Syndromes//Syndrome, Fragile X//Syndromes, Fragile X//Marker X Syndrome//Marker X Syndromes//Syndrome, Marker X//Syndromes, Marker X//Mental Retardation, X-Linked, Associated With Marxq28//X-Linked Mental Retardation and Macroorchidism//X Linked Mental Retardation and Macroorchidism//Fragile X Mental Retardation Syndrome//Martin-Bell Syndrome//Martin Bell Syndrome//Syndrome, Martin-Bell//Fra(X) Syndrome//FRAXE Syndrome//FRAXE Syndromes//Syndrome, FRAXE//Syndromes, FRAXE//Mental Retardation, X-Linked, Associated With Fragile Site Fraxe//Fragile X-F Mental Retardation Syndrome//Mar (X) Syndrome//FRAXA Syndrome//FRAXA Syndromes//Syndrome, FRAXA//Syndromes, FRAXA



Expression Detail

GEO ID:GSE83556
Description:Global transcriptome dysregulation in second trimester fetuses with FMR1 expansions
Experimental Design:Disease vs Control
Case Disease Type:Fragile X Syndrome
Case Disease SubType:NA
Case Sample:Fragile X Syndrome
Control Sample:Normal
Number of Case:22
Number of Control:18
Number of Samples:40





Regulatory Relationship

mRNA targets:
Gene SymbolChromosomeStart Site(bp)End Site(bp)Strand
ABCB10
chr1
229516582
229558707
-
ABHD4
chr14
22598237
22613215
+
AC004805.1
chr17
65538102
65641033
-
AC010132.3
chr7
42909273
42932174
-
AC023055.1
chr12
55757275
55827546
-
AC073896.1
chr12
56285916
56316059
-
AC104109.3
chr5
134167170
134226071
-
ACO2
chr22
41469117
41528989
+
ACTB
chr7
5527148
5563784
-
ACTR2
chr2
65227753
65271253
+
ADAM10
chr15
58588809
58749791
-
ADD3
chr10
109996368
110135565
+
ADNP
chr20
50888916
50931437
-
AFTPH
chr2
64524305
64593005
+
AGO1
chr1
35869808
35930532
+
AHCY
chr20
34280268
34311802
-
AK3
chr9
4709556
4742043
-
AL645941.2
chr6
32937364
32953122
-
ALCAM
chr3
105366909
105576900
+
ALDOA
chr16
30064164
30070457
+
miRNA targets:NA
circRNA targets:NA
lncRNA targets:
lncRNA SymbolChromosomeStart Site(bp)End Site(bp)Strand
AC007218.1
chr16
9666885
9676843
-
AC019294.2
chr15
75737820
75763322
+
AC021078.1
chr5
149494314
149504670
-
AC026362.1
chr12
122975320
122982907
+
AC087190.3
chr16
9104848
9113181
+
AC087280.2
chr11
6821942
6926878
-
AC117386.2
chr3
150039214
150213726
+
AC124068.2
chr15
89335053
89336161
+
AC245014.3
chr1
145281116
145281462
+
AD000090.1
chr19
35557956
35581954
+
Display:



Experiment Detail

GEO ID:GSE83556
Sample Source:Amniotic Fluid
Source Fraction:Supernatant
Platform:GPL570
Method:Microarray
Num of detected RNA Type:1
Num of detected RNAs of this Type:17063
Sample treatment protocol:RNA was extracted from 5-15 mL amniotic fluid supernatant (centrifugation at 350g, 4C, 10, min).
RNA Extract protocol:All samples were processed using the Qiagen Circulating Nucleic Acid kit with an on-column DNase digestion step to remove genomic DNA. The RNA was then purified and concentrated with the RNeasy MinElute Clean up kit and eluted in RNasefree water.
RNA library preparation protocol:RNA was converted to cDNA and amplified using the Ovation Pico WTA kit V2 and then purified with the QIAquick PCR Purification kit. Samples were labeled using the Encore Biotin Module (NuGEN, San Carlos, CA)Samples were labeled using the Encore Biotin Module (NuGEN, San Carlos, CA).



Reference

PMID:NA
Title:NA
Author:NA
Journal:NA
Description:NA